Evidence map›Paper›PMID 28456022›Full record

ArticleVirology2017

Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.

Jason M Biegel, Eric Henderson, Erica M Cox, Gaston Bonenfant, Rachel Netzband, Samantha Kahn, Rachel Eager, Cara T Pager

Abstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. RNA Helicases as Shadow Modulators of Cell Cycle Progression.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Hepatitis C Virus Translation Regulation.International journal of molecular sciences · 2020
    Review
  12. Flavors of Flaviviral RNA Structure: towards an Integrated View of RNA Function from Translation through Encapsidation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jason M BiegelDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Eric HendersonDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Erica M CoxDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Gaston BonenfantDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Rachel NetzbandDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Samantha KahnDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Rachel EagerDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA.
Cara T PagerDepartment of Biological Sciences, The RNA Institute, University at Albany-SUNY, Albany, NY 12222, USA. Electronic address: ctpager@albany.edu.
University at Albany, State University of New York · USStanford University · US

Funding

Roles for microRNA-122 in hepatitis C virus RNA amplificationR01AI069000 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2006 to 2022
$6.2M
Structure and Function of the Hepatitis C Virus GenomeR37AI047365 · NIAID · STANFORD UNIVERSITY · PI SARNOW, PETER · 2011 to 2019
$4.0M
THE PROKARYOTIC-LIKE IRES IN HCV AS A DRUG TARGETR01AI047365 · NIAID · STANFORD UNIVERSITY · PI PUGLISI, JOSEPH D, SARNOW, PETER · 1999 to 2010
$3.8M
NIAID NIH HHS R01 AI047365NIAID NIH HHS R01 AI069000NIAID NIH HHS R37 AI047365
6 · The paper itself

Abstract

Hepatitis C virus (HCV) subverts the cellular DEAD-box RNA helicase DDX6 to promote virus infection. Using polysome gradient analysis and the subgenomic HCV Renilla reporter replicon genome, we determined that DDX6 does not affect HCV translation. Rather expression of the subgenomic HCV Renilla luciferase reporter at late times, as well as labeling of newly synthesized viral RNA with 4-thiouridine showed that DDX6 modulates replication. Because DDX6 is an effector protein of the microRNA pathway, we also investigated its role in miR-122-directed HCV gene expression. Similar to sequestering miR-122, depletion of DDX6 modulated HCV RNA stability. Interestingly, miR-122-HCV RNA interaction assays with mutant HCV genomes sites and compensatory exogenous miR-122 showed that DDX6 affects the function of miR-122 at one particular binding site. We propose that DDX6 facilitates the miR-122 interaction with HCV 5' UTR, which is necessary for stabilizing the viral genome and the switch between translation and replication.

Indexed as

5' Untranslated RegionsCell Line, TumorDEAD-box RNA HelicasesHepacivirusHepatitis CHumansMicroRNAsProto-Oncogene ProteinsRNA, Viral5' Untranslated RegionsDDX6 protein, humanDEAD-box RNA HelicasesMicroRNAsMIRN122 microRNA, humanProto-Oncogene ProteinsRNA, ViralDDX6DEAD-box RNA helicaseHepatitis C virusmiR-122ReplicationRNA stability

Identifiers

PMID28456022
PMCPMC5549679
OpenAlexW2608181902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.